Clinical Trials Browser

Phase 3 × Cabergoline × Endocrine × Clear all

NCT03271918 2017-09-07

Cabergoline in Nonfunctioning Pituitary Adenomas

Phase 3 Completed

Pituitary Neoplasms

NCT00889525 2009-04-29

Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor

Phase 3 Completed

Pituitary ACTH Hypersecretion, ACTH-Secreting Pituitary Adenoma